Skip to main content

Table 1 Clinical details

From: Paclitaxel-induced neuropathy: potential association of MAPT and GSK3B genotypes

Clinical variables  
Age (mean ± sem; years) 51.4 ± 2.1
 Range (years) 33 – 68
% Female 95.2%
Cumulative paclitaxel dose (mg/m2) 965.5 ± 80
 Range (mg/m2) 420 - 2230
Estrogen and/progesterone receptor positive 80%
HER-2/neu positive 40%
Cancer type – breast cancer 95.2%
Cancer stage  
 I - IIB 47.6%
 IIIA - IIIB 47.6%
 IV 4.8%